VANCOUVER, BC / ACCESS Newswire / June 30, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce, further to its news ...

The U.S. Lipid Nanoparticle CDMO Market is projected to reach USD 0.44 billion by 2035, while Europe is expected to reach USD 0.27 billion, driven by expanding mRNA, siRNA, gene-editing therapeutics, ...

Proven bacterial, viral, conjugate, and E.coli expression platforms support partners from discovery and process development to GMP readiness and clinical manufacturing ...

Publication Highlights Novel Intravenous Everolimus Formulation and Demonstrates Broad Potential of Deciparticle™ Technology for Hydrophobic ...

Mood and anxiety disorders represent a leading cause of disability worldwide. Current first-line pharmacological treatments, ...

Automated quality control using rapid PCR assays is replacing 28-day culture tests, cutting biopharmaceutical lot release ...

In recent years, the concept of postbiotics has gained substantial as an increase of microbiome-based therapies. In contrast to probiotics, postbiotics are ...

Millionaire Bryan Johnson revealed his battle with autoimmune gastritis, a condition where the immune system attacks the ...

HydroGraph Clean Power (CSE:HG) launched Fractal Graphene Paste, a ready-to-use dispersion designed to simplify industrial ...

FDA Issues CRL to Sobi for NASP in Uncontrolled Gout, but the letter did not attack the clinical case. It attacked ...

Flu season is no longer just flu season. Since 2022, the health care community has faced what's known as a "tripledemic" of ...

A later generation of ATS cases involved multinational corporations accused of aiding and abetting state human rights ...